Xingzheng strategy: the shareholding concentration of northward capital science and Innovation Board continues to be high
Financial Associated Press, October 16 (Xinhua) Xingzheng strategy believes that the shareholding concentration of northward capital science and Innovation Board continues to be high. As of October 15, the top ten stocks in the science and Technology Innovation Board of Beishang capital are Jinshan Office (RMB 3.467 billion), Haier Biology (RMB 2.208 billion), Chuanyin holding (RMB 1.835 billion), RuiChuang Weina (RMB 1.777 billion), Zhongwei company (RMB 1.689 billion), LanChi Technology (RMB 1.548 billion), stone technology (RMB 762 million), Hangke Technology (RMB 762 million) and kangxinuo-u (RMB 705 million) And Baichu Electronics (RMB 683 million), the top ten heavyweight stocks accounted for 83.83% of the stock market value held by the science and technology innovation board, and the shareholding concentration continued to remain high.
This text is a result of machine translation.
Related companies：
Briefing Jun 27, 2022 04:10 PM
Stone technology: it is planned to use about 460million yuan of over raised funds to increase the capital of Huizhou stone for the investment and construction of self built manufacturing center project
Briefing Jun 25, 2022 08:10 AM
· Technology
There were 89 financing cases in the primary market this week, with an increase of 11.25% month on month. Zhongxin wafer obtained a strategic investment of 1.1 billion yuan
In-depth
Briefing Jun 21, 2022 10:24 AM
· Consumer Discretionary
The United States and Morocco hold joint military exercises
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing Jun 09, 2022 08:44 AM
· Technology
CITIC Securities: the development of the information innovation industry continues to deepen, with an annual scale of over 20/40 billion and is expected to speed up gradually
Briefing Jun 01, 2022 03:58 AM
· Consumer Staples
JD home appliances: 618 pre-sale payment of the balance opened for 10 minutes, and the turnover was 3 times higher than that of last year
Healthcare
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
Insight
See more
Read next
Insight
In-depth
Insight
In-depth